RxDoctor Payments Data

Joel Bachman, PA

Physician Assistant · Brownwood, TXNPI 1447390380

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $623 of the $840 with a category attached, or 74.1%. 9 manufacturers reported payments, led by Medical Device Business Services, Inc. at 50.9% of the total. Reporting peaked in 2023 at $669 and has fallen 79.4% since, to $138 in 2025.

$840in general payments, 2019–2025

Across 18 payments — averaging $46.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$428
  • Johnson & Johnson$172
  • Stryker$90
  • Pylant Medical$41
  • Amgen$37
  • Smith+Nephew$27
  • plus $44 from 3 others

What the payments were for

  • Travel & lodging$21726%
  • Food & beverage$62374%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$840 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Medicare billing

Part B allowed, 2024
$96,361
Medicare patients
311
Services billed
7,270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin131$1,664
Cyclobenzaprine Hcl11$416
Naproxen42$292
Meloxicam21$85
Tramadol Hcl16$84

Paid to pharmacies, not to this prescriber.

Other physician assistant in Brownwood

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →